Candida krusei fungemia in an immunocompromised patient.
Candida krusei is an emerging fungal pathogen found primarily in immunocompromised patients. Intrinsic resistance to fluconazole and decreasing susceptibility to other anti-fungal agents are problematic. When colonization occurs, dissemination may follow rapidly. We present a case of a patient with acute lymphoblastic leukemia who, despite being treated prophylactically with fluconazole, developed disseminated C. krusei.
Hager
Jonathan L
JL
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Mir
Mohsin R
MR
Hsu
Sylvia
S
D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida; D002179:Candidiasis, Cutaneous / Q000175:diagnosis* / Q000276:immunology* / Q000517:prevention & control; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000175:diagnosis* / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D015456:Leukemia, Biphenotypic, Acute / Q000150:complications* / Q000276:immunology; D008297:Male; D055815:Young Adult
D000935:Antifungal Agents; D015725:Fluconazole